[Use of prostacyclin in patients with ischemic stroke. A double-blind method II].
Copyright policy )[Use of prostacyclin in patients with ischemic stroke. A double-blind method II].
Thirty patients with acute ischaemic stroke were allocated randomly into a group treated with prostacyclin and a group receiving placebo. The treatment was started 24 to 72 hours after the onset of stroke. Prostacyclin sodium (Wellcome, U.K. or Chinoin, HPR) or its solvent (glycine buffer) were administered intravenously once daily during 2 weeks in 6-hour infusions. Prostacyclin was infused at rates of 2.5-5.0 ng/kg/min. Statistically significant improvement appeared from the second day on in the prostacyclin group, and only from the eighth day on in the placebo group. However, the final improvement was not statistically different between these groups.
Adult, Male, Clinical Trials as Topic, Cerebral Infarction, Middle Aged, Epoprostenol, Brain Ischemia, Double-Blind Method, Prostaglandins, Synthetic, Humans, Female, Aged
Adult, Male, Clinical Trials as Topic, Cerebral Infarction, Middle Aged, Epoprostenol, Brain Ischemia, Double-Blind Method, Prostaglandins, Synthetic, Humans, Female, Aged
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!